Please assess the completion status of the following clinical trial:

Trial Title: Scleroderma ARFI Imaging of the Skin

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. 18 years of age or older~2. Rheumatologic disease of the skin including: Limited Scleroderma, Diffuse Scleroderma, or Eosinophilic Fascitis (Schulman's Syndrome)~Exclusion Criteria:~1. None

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- ARFI-SVI Ultrasound (Type: None): Ultrasound imaging of forearm and thigh, lasting approximately 5-10 minutes.
- Healthy Volunteers: ARFI/SVI Ultrasound (Type: None): Ultrasound imaging of forearm and thigh, lasting approximately 5-10 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).